SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manu...

FDA Recall #D-0144-2024 — Class I — November 22, 2023

Recall #D-0144-2024 Date: November 22, 2023 Classification: Class I Status: Ongoing

Product Description

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

Reason for Recall

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Recalling Firm

Novartis Pharmaceuticals Corporation — East Hanover, NJ

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

6,997 bottles

Distribution

Nationwide within the United States

Code Information

Lot #: FX001500, FX001582, Exp. 09/30/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated